logo

For the Inventor, By the Inventor

Fullinsdorf, Switzerland

Herbert Schroter

USPTO Granted Patents = 21

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 145(Granted Patents)


Company Filing History:

goldMedal20 out of 6,850 
 
Ciba-geigy Corporation
 patents
silverMedal1 out of 1 
 
C-g Corp.
 patent

Years Active: 1976-1983

Loading Chart...
21 patents (USPTO):Explore Patents
1. 4410530 - 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines (1983-10-18),
2. 4310527 - Etherified hydroxy quinazolone compounds (1982-01-12),
3. 4304912 - Piperidine derivatives (1981-12-08),
4. 4264599 - Piperidino-propanols (1981-04-28),
5. 4217350 - Oxygenated N-aryl-diazacyclic compounds (1980-08-12),
6. 4195090 - 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical (1980-03-25),
7. 4144344 - Antihypertensive 1-substituted-4-(2-oxo-1-imidazolidinyl) piperidines (1979-03-13),
8. 4140789 - Etherified hydroxy-benzodiheterocyclic compounds (1979-02-20),
9. 4139623 - Cyclic-substituted derivatives of 1-amino-2-propanol (1979-02-13),
10. 4115575 - 2-(3-Amino-2-hydroxy-propoxy)-pyrazines (1978-09-19),
11. 4075335 - Pharmaceutical piperidine derivatives (1978-02-21),
12. 4075208 - 1-Substituted-4-(2-oxo-hexahydro-1-pyrimidinyl)-piperidine (1978-02-21),
13. 4049797 - Composition and method for treatment of heart and circulatory ailments (1977-09-20),
14. 4038414 - Amines and processes for their manufacture (1977-07-26),
15. 4027027 - Pyridyloxyalkyleneamino-phenoxy-propanol-2-compounds (1977-05-31),

Title: Herbert Schroter: Pioneering Innovator in the Field of Technology

Introduction:

Herbert Schroter, a visionary inventor based in Fullinsdorf, Switzerland, has made significant contributions to the world of technology with his groundbreaking inventions and patents. With a total of 21 patents to his name, Schroter is known for his relentless pursuit of innovation and commitment to creating a more sustainable future through his work.

Latest Patents:

Schroter's latest patents include compounds like 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines and etherified hydroxy quinazolone compounds. These compounds have valuable applications as cardioselective beta-receptor blocking agents and stimulants, offering promising solutions for disorders in cardiac rhythm and coronary heart diseases.

Career Highlights:

Having worked with renowned companies such as Ciba-Geigy Corporation and C-G Corp., Herbert Schroter has solidified his reputation as a trailblazer in the field of technology. His innovative approaches and novel inventions have paved the way for advancements in pharmaceuticals and medical treatments, showcasing his diverse skill set and knowledge in the industry.

Collaborations:

Throughout his career, Schroter has collaborated with esteemed colleagues like Franz Ostermayer and Knut A. Jaeggi. Together, they have synergized their expertise to develop cutting-edge solutions and push the boundaries of technological possibilities, fostering a culture of innovation and collaboration in the workplace.

Conclusion:

In conclusion, Herbert Schroter stands as a beacon of innovation, consistently pushing the boundaries of what is possible in the world of technology. His relentless pursuit of excellence and commitment to creating a more sustainable future make him a true visionary in the field of inventions, leaving a lasting impact on the industry and inspiring future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…